Novel hybrids of drug with bioactive heterocycles for enhancing biological activity.

about

A chiral cobalt(ii) complex catalyzed asymmetric formal [3+2] cycloaddition for the synthesis of 1,2,4-triazolines.

P2860

Q48360715-2F62FC55-8099-4FBC-9659-AC611F6D6260

P2860

Novel hybrids of drug with bioactive heterocycles for enhancing biological activity.

Item

http://www.wikidata.org/entity/Q46367131

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Novel hybrids of drug with bioactive heterocycles for enhancing biological activity.

@en

Novel hybrids of drug with bioactive heterocycles for enhancing biological activity.

@nl

type

Item

label

Novel hybrids of drug with bioactive heterocycles for enhancing biological activity.

@en

Novel hybrids of drug with bioactive heterocycles for enhancing biological activity.

@nl

prefLabel

Novel hybrids of drug with bioactive heterocycles for enhancing biological activity.

@en

Novel hybrids of drug with bioactive heterocycles for enhancing biological activity.

@nl

P1476

Novel hybrids of drug with bioactive heterocycles for enhancing biological activity

@en

P2093

Muthu K Kathiravan

http://www.w3.org/2001/XMLSchema#string

Parthiban Valentina

http://www.w3.org/2001/XMLSchema#string

P2860

NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling

New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells

Aromaticity as a Cornerstone of Heterocyclic Chemistry

Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects.

Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines.

Molecular hybridization: a useful tool in the design of new drug prototypes.

Synthesis and biological evaluation of 3,4-diaryl-5-aminoisoxazole derivatives.

1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.

New 5-substituted thiazolo[3,2-b][1,2,4]triazol-6-ones: synthesis and anticancer evaluation.

New bis-aminomercaptotriazoles and bis-triazolothiadiazoles as possible anticancer agents.

P2888

s12272-016-0797-6

P304

1382-1390

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12272-016-0797-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kaliappan Ilango

P577

2016-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27469336

http://www.w3.org/2001/XMLSchema#string

Novel hybrids of drug with bioactive heterocycles for enhancing biological activity.

about

P2860

P2860

Novel hybrids of drug with bioactive heterocycles for enhancing biological activity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698